Clinical Trials · NCT07822061
AMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose Weight
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 400
- Start date
- Sep 2026
- Locations
- 26 sites, Japan
- Primary endpoint
- Relative change in body weight